Nagarro【NA9】銘柄情報 | ADVFN

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
ドイツ
TG
Nagarro SE (NA9) 銘柄情報

Nagarro SE (NA9)

85.95

6.10

(7.64%)

終了 9月29日 5:00AM

リアルタイムデータ

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

85.95

買値

85.10

売値

86.75

出来高

8,540

79.00 日の範囲 87.80

63.35 52 週間の範囲 94.35

時価総額

前日終値

79.85

始値

79.00

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

1,394

発行済株式数

13,775,985

配当利回り

2.23%

PER

0.00

1 株当たり利益 (EPS)

-

歳入

922.9M

純利益

52.14M

セクター

Management Consulting Svcs

業界

Management Consulting Svcs

ウェブサイト

www.nagarro.com

本社

Munich, Deu

設立

-

Nagarro SE is listed in the Management Consulting Svcs sector of the Tradegate (DE) with ticker NA9. The last closing price for Nagarro was 79.85 €. Over the last year, Nagarro shares have traded in a share price range of 63.35 € to 94.35 €.

Nagarro currently has 13,775,985 shares in issue. The market capitalisation of Nagarro is 1.10 € billion.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	5.4	6.70391061453	80.55	87.8	76.4	1000	78.66645648	DE
4	10.2	13.4653465347	75.75	87.8	70.349999	1038	76.32822152	DE
12	8.5	10.9748224661	77.45	87.8	70.349999	1394	76.33708755	DE
26	9.4	12.2795558459	76.55	91.05	66.599999	1641	76.98043326	DE
52	19.4	29.151014275	66.55	94.35	63.35	1883	80.22158425	DE
156	-69.55	-44.7266881029	155.5	212	62.5	20464	113.75797567	DE
260	16.95	24.5652173913	69	212	62.5	19945	111.95495577	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
7KOCullinan Metals Corp	0.0104 € (52.94%)	40k
NL8Genesis Ai Corp	0.0228 € (52.00%)	6.6k
0T8BTCTM Kids IT Education Inc	1.17 € (45.34%)	11.25k
1UCCue Biopharma Inc	0.57 € (41.09%)	3k
RT5New World Solutions Inc	0.0214 € (39.87%)	1.2k
W7ZPatterson Metals Corp	0.2522 € (-40.66%)	15.23k
7S2Scotch Creek Ventures Inc	0.009 € (-40.00%)	4k
9HBKomo Plant Based Foods Inc	0.01 € (-33.33%)	3k
3ACActinogen Medical Limited	0.0155 € (-32.61%)	35.92k
CNWCodon AG	0.009 € (-28.00%)	100
D7GNel ASA	0.417 € (0.72%)	8.46M
O8DBedford Metals Corp	0.615 € (-12.14%)	2.95M
3CPXiaomi Corporation	2.54 € (1.62%)	1.63M
CBKCommerzbank AG	16.40 € (-0.43%)	1.54M
GRUGeely Automobile Holdings Ltd	1.378 € (6.00%)	1.52M

Seminole Red

Seminole Red 4分前

https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/461522068_1031351608783731_4018675135025608390_n.jpg?stp=cp6_dst-jpg&_nc_cat=1&ccb=1-7&_nc_sid=833d8c&_nc_ohc=JVDgd6vCdLIQ7kNvgEmxVNf&_nc_ht=scontent-mia3-1.xx&_nc_gid=AHTOQKIUGhzb5lceYVfZ3V7&oh=00_AYCQDHIRbrgJLlhXdaxG8R06EqH9avDr86F35IOYUWhLEg&oe=6

MartinLutherKing

MartinLutherKing 4分前

News can hit in any direction now , Partnership, Acquisition, Fda fast
track, Merger, royalties from the swiss alps

weedtrader420

weedtrader420 5分前

Best weed☀️😁👍 brings a smile to your face

Seminole Red

Seminole Red 5分前

https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/461522068_1031351608783731_4018675135025608390_n.jpg?stp=cp6_dst-jpg&_nc_cat=1&ccb=1-7&_nc_sid=833d8c&_nc_ohc=JVDgd6vCdLIQ7kNvgEmxVNf&_nc_ht=scontent-mia3-1.xx&_nc_gid=AHTOQKIUGhzb5lceYVfZ3V7&oh=00_AYCQDHIRbrgJLlhXdaxG8R06EqH9avDr86F35IOYUWhLEg&oe=6

georgejjl

georgejjl 6分前

“…We are also pleased to report that the clinical team continues to beat the planned timelines in the ongoing Phase 2 clinical trial of ANAVEX®3-71 in schizophrenia patients. We have completed dosing of the first cohort and are nearing the completion of enrollment of the second cohort of schizophren

vator

I do not get that impression. Ten years and they will have the most market share. Doesn’t mean limiting revenue along the way.

vinnie1965

vinnie1965 11分前

style="font-size: 16px"Mount Vernon is on the way to Vegas, Rudolph is off ramp exit of the highway just pass the Cajon Pass

urge2surge

urge2surge 11分前

Yep the investor factor is huge. 10% retention is more than reasonable. Given the additional roll out, especially looking forward to the horse races. This has already doubled on marketing views from yesterday's post, 2.7k to 5.5k. Fwiw I think the majority of the outstanding is already in traders

Reluctant Observer

Reluctant Observer 12分前

I was paid for over a decade, but I started pissing off huggy bear lol

Zorax

That would be absolutely great.
He'd never pay though.

trunkmonk

trunkmonk 12分前

I believe the end of the appeal is a week away, nothing will really open up until then.

Xunefox

Xunefox 12分前

How far are you from Mount Vernon?

Viking61

Viking61 12分前

Breaking, new Atlasintel poll which was considered the most correct poll in 2020 has Trump up in five out of seven swing states! This includes Michigan and Pennsylvania!!

RMS555

RMS555 13分前

lolololol.... advise from you, LMFAO!!!!!! I like KEGS alot, and I will like it more next week but I will slow down buying KEGS after it reaches .0003 (this trading week)...... In am 99% invested into KEGS with money I can afford to lose!

This account is just play money for me, I wil

waterchaser

waterchaser 15分前

Spot-on self description. Thanks!

ChartTRACKER

ChartTRACKER 15分前

Looks like they're diluting?
Or is it just people dumping?

Either way NOT good at all. I hope it's NOT dilution 'csuse it would mean that they have NO REVENUE!
And so all of what they claimed in past is BOGUS!

frrol

It will be good to see it. Presenting the S1 sub grouping at a scientific conference is encouraging, as it somewhat implies stat-sig correlation to benefit. If that's the case, that would mean a couple things: while non-S1wt would be seeing less-to-no benefit, a rational biomarker can strongly suppo

blackhawks

blackhawks 18分前

Vance is doing the same thing he did with the Haitians:

https://www.npr.org/2024/09/15/nx-s1-5113140/vance-false-claims-haitian-migrants-pets

Sen. Vance said. "If I have to create stories so that the American media actually pays attention to the suffering of the Americ

europa7

europa7 18分前

Bank of Korea Prepares to Launch CBDC Payment Pilot in Retail Sector
September 24, 2024
https://digitalpoundfoundation.com/bank-of-korea-prepares-to-launch-cbdc-payment-pilot-in-retail-sector/

December CBDC Trial Aims to Transform Retail Payments
"...According to

BacTech Environmental

Intesa Sanpaolo

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約